Does Cefzil (cefprozil) cause side effects?

Cefzil (cefprozil) is a cephalosporin antibiotic effective against susceptible bacteria causing infections of the middle ear, tonsils (tonsillitis), throat (pharyngitis), larynx (laryngitis), bronchi (bronchitis), skin and soft tissues, and lungs (pneumonia). 

Cephalosporins stop or slow the growth of bacterial cells by preventing bacteria from forming the cell wall that surrounds each cell. The cell wall protects bacteria from the external environment and keeps the contents of the cell together. Without a cell wall, bacteria are not able to survive.

Common side effects of Cefzil include

Serious but rare side effects of Cefzil include

Drug interactions of Cefzil include probenecid, which may increase the blood concentration of Cefzil by decreasing excretion of Cefzil by the kidney. This interaction is sometimes used to enhance the effect of cephalosporins.

  • Combining Cefzil with aminoglycosides (for example, tobramycin) produces additive bacterial killing effects but also may increase the risk of harmful effects to the kidney.
  • Exenatide may delay or reduce the absorption of cephalosporins.
  • Cephalosporins should be administered one hour before exenatide.
  • Cefzil may cause false test results with some tests for sugar in the urine. 

There are no adequate studies of Cefzil in pregnant women. 

Small amounts of Cefzil are secreted in breast milk, but the effect on the infant is unknown. Consult your doctor before breastfeeding

What are the important side effects of Cefzil (cefprozil)?

Cefprozil is generally well tolerated. The most common side effects are:

Rare side effects include abnormal liver tests and allergic reactions. Like most antibiotics cefprozil may cause a condition called pseudomembranous colitis, a potentially serious bacterial infection of the colon. Persons with phenylketonuria should be advised that the suspension contains phenylalanine.

Cefzil (cefprozil) side effects list for healthcare professionals

The adverse reactions to cefprozil are similar to those observed with other orally administered cephalosporins. Cefprozil was usually well tolerated in controlled clinical trials. Approximately 2% of patients discontinued cefprozil therapy due to adverse events.

The most common adverse effects observed in patients treated with cefprozil are:

Gastrointestinal

Hepatobiliary

As with some penicillins and some other cephalosporin antibiotics, cholestatic jaundice has been reported rarely.

Hypersensitivity

Such reactions have been reported more frequently in children than in adults. Signs and symptoms usually occur a few days after initiation of therapy and subside within a few days after cessation of therapy.

CNS

All were reversible.

Hematopoietic

Renal

Other

The following adverse events, regardless of established causal relationship to CEFZIL (cefprozil), have been rarely reported during postmarketing surveillance:

Cephalosporin class paragraph

In addition to the adverse reactions listed above which have been observed in patients treated with cefprozil, the following adverse reactions and altered laboratory tests have been reported for cephalosporin-class antibiotics:

Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment, when the dosage was not reduced. If seizures associated with drug therapy occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically indicated.

What drugs interact with Cefzil (cefprozil)?

  • Nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporin antibiotics. Concomitant administration of probenecid doubled the AUC for cefprozil.
  • The bioavailability of the capsule formulation of cefprozil was not affected when administered 5 minutes following an antacid.

Drug/Laboratory Test Interactions

  • Cephalosporin antibiotics may produce a false positive reaction for glucose in the urine with copper reduction tests (Benedict's or Fehling's solution or with Clinitest tablets), but not with enzyme-based tests for glycosuria (eg, Clinistix).
  • A false negative reaction may occur in the ferricyanide test for blood glucose.
  • The presence of cefprozil in the blood does not interfere with the assay of plasma or urine creatinine by the alkaline picrate method.

Summary

Cefzil (cefprozil) is a cephalosporin antibiotic effective against susceptible bacteria causing infections of the middle ear, tonsils (tonsillitis), throat (pharyngitis), larynx (laryngitis), bronchi (bronchitis), skin and soft tissues, and lungs (pneumonia). Common side effects of Cefzil include diarrhea or loose stools, nausea, abdominal pain, vomiting, rash, and headache. There are no adequate studies of Cefzil in pregnant women. Small amounts of Cefzil are secreted in breast milk, but the effect on the infant is unknown.

Treatment & Diagnosis

Medications & Supplements

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Medically Reviewed on 1/19/2021
References
FDA Prescribing Information

Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.
CONTINUE SCROLLING FOR RELATED SLIDESHOW